Related Experiment Video
Updated: May 11, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Rectal Cancer Disparities Among the American Indian/Alaskan Native Populations.
Broc S Kelley1, Cibele B Carroll2, John M Hampton2
1Department of Medicine, Division of Hematology, Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
American Indian/Alaskan Native (AI/AN) individuals diagnosed with rectal cancer are younger and present with more advanced disease. AI/AN race is linked to lower overall survival (OS) compared to White patients, highlighting a need for improved screening and treatment access.
Area of Science:
- Oncology
- Health Disparities
- Epidemiology
Background:
- Previous research indicated lower overall survival (OS) for American Indian/Alaskan Native (AI/AN) individuals with colon cancer compared to non-Hispanic White (NHW) populations.
- Demographic and survival data for rectal cancer in AI/AN populations remain underreported.
Purpose of the Study:
- To investigate disparities in rectal cancer diagnosis and outcomes between AI/AN and White patient groups.
- To identify differences in demographic profiles and survival rates for rectal cancer between these populations.
Main Methods:
- Utilized the National Cancer Database (NCDB) to identify White and AI/AN patients diagnosed with rectal adenocarcinoma between 2004 and 2020.
- Performed unadjusted and adjusted analyses to compare demographic and clinical characteristics, including standardized differences (stddiff).
- Conducted survival analyses for Stage II/III rectal cancer using Kaplan-Meier methods and multivariate Cox-proportional hazards modeling.
Main Results:
- Identified 176,341 eligible cases (0.6% AI/AN, 99.4% White).
- AI/AN patients were diagnosed at a younger mean age (59.9 vs. 64.5 years) and presented with more advanced stage disease (44.8% vs. 43.7%).
- AI/AN patients disproportionately resided in lower-income areas (35.5% vs. 15.1%), rural locations (9.9% vs. 2.2%), and primarily used Medicaid (14.3% vs. 6.2%).
- Adjusted analyses revealed an increased hazard of death for AI/AN patients (HR, 1.14; 95% CI, 1.05-1.25; p=0.003).
Conclusions:
- AI/AN individuals with rectal cancer are diagnosed at a younger age and with more advanced disease.
- AI/AN race is independently associated with lower overall survival compared to White patients.
- Future interventions should prioritize enhanced colorectal cancer screening and improved treatment access for AI/AN populations to improve survival outcomes.
More Related Videos
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Related Concept Videos
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Abdominal Regions and Quadrants
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...